Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00390455
Status:
COMPLETED
Last Update Posted:
2019-12-20
First Post:
2006-10-18
Brief Title:
Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2006-09-15
Start Date Type:
ACTUAL
Primary Completion Date:
2014-07-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-07-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-10-18
First Submit QC Date:
October 18 2006
Study First Post Date:
2006-10-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2015-06-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-12-09
Last Update Post Date:
2019-12-20
Last Update Post Date Type:
ACTUAL